Defining the mechanisms by which FXI plays a role in propagating inflammation will provide insight into whether FXI inhibition has potential therapeutic anti-inflammatory benefits in cardiovascular disease and, in particular, hyperlipidemia. This evidence concerns the gene F11 and cardiovascular disorder.